NEW YORK (360Dx) – Quest Diagnostics announced Tuesday it will acquire the US laboratory testing business of Oxford Immunotec Global for $170 million in cash.
As part of the definitive agreement reached by the companies, the acquisition will include the T-Spot.TB tuberculosis testing service and the Accutix tick-borne disease testing service provided by Oxford Immunotec laboratories in Norwood, Massachusetts and in Memphis, Tennessee. Oxford Immunotec is headquartered in Abingdon, UK.